ACIU
#3394
AC Immune SA - Common Stock
2.4 1 USD
-0.02%
Market Price
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
Jahresspanne
Tagesänderung
-1.63%
Monatliche Änderung
-11.72%
6 month change
-27.19%
Jahresänderung
-29.74%
Vorheriger Schlusskurs
2.4 5
Open
2.4 3
Tief
2.3 9
Hoch
2.4 4
Financials
- Market Capitalization 245.2 M
- Employee 122
- Founded 2003
- CEO Andrea Pfeifer
- Website www.acimmune.com
- Headquarter Switzerland
- FIGI UNKNOWN
- Industry Biotechnologie
Related tickers
| # | Name | Preis | 24h % | 7d % | 1M % | 1J % | Marktkapitalisierung | Letzte 7 Tage | |
|---|---|---|---|---|---|---|---|---|---|
| 3380 |  IKT Inhibikase Therapeutics, Inc. - Common Stock | 1.76 USD | -4.86% | -11.11% | -24.79% | +11.39% | 245.58 M USD | ||
| 3389 |  RCKT Rocket Pharmaceuticals, Inc. - Common Stock | 2.31 USD | -6.85% | -6.85% | -29.79% | -41.07% | 253.58 M USD | ||
| 3402 |  SABS SAB Biotherapeutics, Inc. - Common Stock | 2.69 USD | -4.95% | -8.19% | -21.35% | +17.47% | 244.75 M USD | ||
| 3405 |  BBOT BridgeBio Oncology Therapeutics, Inc. - Common Stock | 2.94 USD | -9.82% | -16.00% | -40.12% | -74.32% | 235.71 M USD |